Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India
· Delayed Price · Currency is INR 124.00
-4.25 (-3.31%)
At close: May 20, 2025
NSE:ARISTO Revenue
Aristo Bio-Tech and Lifescience had revenue of 2.14B INR in the half year ending September 30, 2024, with 65.91% growth. This brings the company's revenue in the last twelve months to 3.26B, up 47.30% year-over-year. In the fiscal year ending March 31, 2024, Aristo Bio-Tech and Lifescience had annual revenue of 2.45B with 12.53% growth.
Revenue (ttm)
3.26B
Revenue Growth
+47.30%
P/S Ratio
0.26
Revenue / Employee
65.29M
Employees
50
Market Cap
844.17M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,155.91B |
| Infosys | 1,647.16B |
| Bajaj Finance | 369.88B |